Work

Circulating Tumor DNA Identifies EGFR Coamplification as a Mechanism of Resistance to Crizotinib in a Patient with Advanced MET-Amplified Lung Adenocarcinoma

Year: 2017

Type: article

Study design: Case Report

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2017.04.023

Authors: Ibiayi Dagogo-Jack, David Fabrizio, Jochen Lennerz, Alexa B. Schrock, Lauren Young, Mari Mino-Kenudson, Subba R. Digumarthy, Rebecca S. Heist, Siraj M. Ali, Vincent A. Miller, Alice T. Shaw

Institutions: Massachusetts General Hospital, Foundation Medicine (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

Award: G417794582

OpenAlex ID: W2613620759

FWCI: 1.012

Cites: 8

Cited by: 8

Related to: 10